Active	Status	Sponsor type	Region	Phase	Filter
4 Active 2 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zarbock
AKITA, NCT05126303: Efficacy and Safety of RMC-035 in Subjects at High Risk for Acute Kidney Injury Following Open-Chest Cardiac Surgery	Terminated	2	177	Europe, Canada, US, RoW	RMC-035, ROSgard, Placebo	Guard Therapeutics AB	Acute Kidney Injury	04/23	07/23
CRRTInfO, NCT05450185: Filter Lifespan in Continuous Renal Replacement Therapy	Recruiting	N/A	600	Europe, RoW	Critically ill patients with continuous renal replacement therapy	University Hospital Muenster, Baxter Healthcare Corporation	Critically Ill, Continuous Renal Replacement Therapy, Infections	05/25	08/25
BigpAK-2, NCT04647396: Biomarker-guided Intervention to Prevent Acute Kidney Injury	Completed	N/A	1180	Europe	Comprehensive Implementation of the Bundle recommended by the "Kidney Disease: Improving Global Outcomes Group" (KDIGO bundle)	University Hospital Muenster, BioMérieux	Acute Kidney Injury	06/24	09/24
PrevProgAKI, NCT05275218: Effect of an Intervention to Prevent Acute Kidney Injury Versus Standard Care in High-risk Patients After Major Surgery	Recruiting	N/A	480	Europe	Implementation of the KDIGO bundle)	University Hospital Muenster, Baxter Healthcare Corporation	Acute Kidney Injury (Nontraumatic)	09/25	12/25